# Open-Label Creatine Study for Female Meth Users

> **NCT02189915** · NA · TERMINATED · sponsor: **Perry Renshaw** · enrollment: 14 (actual)

## Conditions studied

- Depression
- Dual Diagnosis
- Substance Use

## Interventions

- **DRUG:** Creatine monohydrate

## Key facts

- **NCT ID:** NCT02189915
- **Lead sponsor:** Perry Renshaw
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2015-10
- **Final completion:** 2015-10
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** Received funding for the next phase of the study
- **Last updated:** 2016-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02189915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02189915, "Open-Label Creatine Study for Female Meth Users". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02189915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*